Several strains of Staphylococcus aureus and Staphylococcus epidermidis, exhibiting characteristic resistance patterns to aminoglycoside antibiotics, were examined. The aminoglycoside-modifying enzymes from these strains were purified by DEAE-Sephadex A-50 chromatography, affinity chromatography, and Sephadex G-100 gel filtration. Three enzymes, a 3'-phosphotransferase III (molecular weight, 31,000; pl 4.1), a bifunctional enzyme having 6'-acetyltransferase and 2"-phosphotransferase (molecular weight, 56,000; p1 4.1) activity, and a 4',4"-adenylytransferase (molecular weight, 34,000; pI 4.7), were isolated from crude extracts of the resistant strains. Aminoglycoside-modifying enzymes with identical enzymatic properties derived from S. aureus and S. epidermidis were also immunologically identical.
There have been a number of reports on the mechanisms of resistance to aminoglycosides (AGs) in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis (3, 4, 13, 14, 17, 19, 20, 22, 26, 28) . However, reports on purification of the AG-modifying enzymes from staphylococci are few (13, 14, 21) . Le Goffic (12) reported plasmidcoded resistance to AGs, including gentamicin (GM), and suggested that both acetylation of 6'-NH2 and phosphorylation of 2"-OH was caused by a single modifying enzyme. Recently, transfer and homogeneity of GM resistance plasmids intra-and interspecifically in S. aureus and S. epidermidis were also demonstrated (2, 5, 7, 8, 17, 27) .
We have previously reported on the epidemiology of kanamycin (KM) or GM resistance in S. aureus isolated from clinical material in Japan (9) . Subsequently, plasmids mediating these resistances, referred to as pTU512 (10) , pTUO53, and pTUO68 (23) were studied by ultracentrifugation and electron microscopy. In addition, the modified sites of AGs, using the inactivated products of sisomicin (SISO) and amikacin (AMK), were analyzed by nuclear magnetic resonance (24) .
In this report, we describe the results of further biochemi- resistance from TK053 or TK068 to MS353, respectively. S. aureus TK729 was a wild-type strain from clinical material. Three clinical isolates of S. epidermidis, TK1265, TK406, and TK1043, which had resistance patterns similar to the S. aureus strains, were also examined. The MICs of AGs were determined by the spot method on agar plates containing twofold dilutions of antibiotics. Overnight broth cultures of the strains were used to inoculate these plates with a multipoint replicating apparatus, resulting in a final inoculum of 10 CFU per spot.
Purification of the enzymes. Bacterial strains were grown in 3 liters of tryptic soy broth (Difco Laboratories, Detroit, Mich.) at 37°C with continuous shaking until late logarithmic growth. The cells were harvested by centrifugation and washed twice in PMK buffer [0.1 M phosphate buffer, 60 mM KCl, 10 mM Mg(CH3COO)2 -4H20, 6 mM ,B-mercaptoethanol, 10% glycerol (pH 6.8)]. The bacterial pellet was suspended in 40 ml of PMK buffer and continuously sonicated with an ultrasonicator (9 KHz; Kubota 200M) at 4°C for 60 min. The disrupted cell suspension was centrifuged for 10 min, and the supernatant was collected. Sonication was repeated once, and the supernatant was pooled. The resulting solution (ca. 70 ml) was centrifuged at 100,000 x g for 60 min. The supernatant was collected and designated S-100.
This fraction was applied to a column (1.8 by 35 cm) packed with DEAE-Sephadex A-50. Adsorbed protein was eluted with a linear gradient of NaCl (0 to 1 M) in PMK buffer after washing out with the same buffer. Fractions having enzymatic activity were pooled and dialyzed against PMK buffer to remove the salt. A column (0.9 by 10 cm) was packed with SISO-Sepharose 4B previously prepared by coupling SISO to cyanogen bromide-activated Sepharose 4B (25) . The sample was applied to the column and eluted with a linear gradient of KCl (0.06 to 1 M) in PMK buffer. Fractions having enzymatic activity were pooled and concentrated by a Diaflo apparatus with a PM-10 membrane (Amicon Corp., Lexington, Mass.). The sample was applied to gel filtration on a column (1.8 by 40 cm) packed with Sephadex G-100. Fractions having enzymatic activity were pooled and reapplied to a column (0.9 by 10 cm) packed with DEAESephadex A-50. The enzyme was eluted with a linear gradient of NaCl (0 to 0.6 M) in PMK buffer. Finally, fractions was cut into 5-mm slices and suspended in 0.5 ml of PMK for phosphorylation and adenylylation consisted of 0.25 ml buffer to elute the enzyne from the gel. Enzymatic activity of PMK buffer, 0.15 ml of enzyme solution, 0.05 ml of 40 mM was measured, and the isoelectric point was estimated from ATP, and 0.05 ml of 0.5 mM antibiotic, in a total volume of the pH value of control slices suspended in water. The 0.5 ml. For acetylation, 2 mM acetyl coenzyme A was added enzyme position in the polyacrylamide gel was detected by instead of ATP. After incubation for 1 h at 37°C, the reaction staining with Coomassie brilliant blue G-250. mixture was stopped by being boiled for 3 min.
Preparation of antisera. Rabbit antisera for three enzymes,
The degree of purification of the enzymes was expressed APH(3')-III purified from MS353(pTU512), bifunctional enin units. One unit was defined as the amount of enzyme zyme with AAC(6') and APH(2") purified from MS353 (pTUO68), and AAD(4',4") purified from TK729, were prepared by the method of Matsuhashi et al. (15) . Each inoculation consisted of 100 jig of protein of the purified enzyme mixed with an equal amount of complete Freund adjuvant (Difco). The inoculation was performed subcutaneously into the backs of rabbits (2.5 kg, female) four times at 10-day intervals. Having confirmed the rise in the level of antibodies, we bled the rabbits 7 days after the last inoculation. Immunological studies with the antibody and each enzyme were performed by double immunodiffusion assays by the method of Ouchterlony (18) . RESULTS Substrate profiles for the AG-modifying enzymes. Table 2 shows the substrate profiles for the AG-modifying enzymes prepared from each strain. In the S-100 fraction from S. aureus MS353(pTU512), only phosphotransferase activity was found, and this enzyme appeared to be APH(3')-III from its substrate profile. With regard to S. qureus MS353(pTUO53) and MS353(pTUO68), the presence of both AAC(6') and APH(2") activity was confirmed in the enzymatic preparations. With the exception of HBK, a newly tested antibiotic which was found to be poorly modified, all the other antibiotics listed in Table 2 proved to be excellent substrates for many of these enzymes. In addition to these activities, APH(3')-III activity was found in MS353(pTUO53) (24). In the S-100 fraction from S. aureus TK729, an adenylyltransferase activity was observed. The most efficient substrate for this enzyme was found to be TOB, followed by KM, LVDM, DKB, and AMK; the extent of modification of these antibiotics was at least 70% that seen with TOB. On the contrary, GM, SISO, NTL, and HBK were poorly modified. From these results, it was suggested that this enzyme was AAD(4',4").
A phosphotransferase activity was found in the S-100 fraction from S. epidermidis TK1265 as the only modifying enzyme. Its substrate range indicated that the enzyme modifies the 3'-OH of the target antibiotics. Three enzymatic activities were detected in the S-100 fraction from S. epidermidis TK406, that is, phosphotransferase, acetyltransferase, and adenylyltransferase activities. Based on the substrate profiles, the enzymes were further characterized as AAC(6'), APH(2"), and AAD(4',4"), respectively. The only modifying enzyme present in the S-100 fraction from S. epidermidis TK1043 was an adenylyltransferase whose substrate profile corresponded to that of AAD(4',4"), identical to the one that occurred in S. aureus TK729.
Purification of enzyme. The modifying enzymes extracted from the strains listed in Table 1 were purified after the final step of DEAE-Sephadex A-50 chromatography. The elution pattern of the enzyme from MS353(pTUO68) is shown in Fig.  1 . AAC (6') and APH(2") activities were observed as a single peak when GM was the substrate, and the position corresponded to one of the protein peaks. The specific activity and the recovery rate of two enzymes, AAC(6') and APH(2"), and AAD(4',4"), through the purification steps are summarized in Tables 3 and 4 . In the purification of AAC(6') and APH(2") from extracts of MS353(pTU068), specific activity after DEAE-Sephadex chromatography was 6.0 U/mg. However, the final recovery rate was low (7% of the initial activity). The specific activity of AAD(4',4") from TK729 increased from 1.4 to 201 U/mg after DEAE-Sephadex chromatography ( Table 4 ). The recovery rate was only 19% of the initial activity. The final recovery rate of each enzyme from other strains also ranged from 15 to 23%.
Determination of molecular weight and isoelectric point. Molecular weight values of the enzymes estimated by the gel filtration method and sodium dodecyl sulfate-polyacrylamide gel electrophoresis are shown in Fig. 2 and Table 5 , respectively. The values were almost the same by both procedures. Enzymes with the same functions derived from S. aureus and S. epidermidis had identical molecular weights. The molecular weight of APH(3')-III was 31,000 and that of AAD(4',4") was 36,000. The bifunctional enzyme with AAC(6') and APH(2") activity had a molecular weight of 54,000. Estimation of molecular weights by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Electrophoresis was performed at a constant current of 20 mA. The gel was removed from the apparatus, stained for 3 h with 0.1% Coomassie brilliant blue R in 50% methanol-10% acetic acid, and diffusion-destained with several changes of 5% methanol-10% acetic acid. Bifunctional enzyme AAC(6') and APH(2") activity (lanes): A, MS353(pTUO68); B, MS353(pTUO53); C, TK406. AAD(4',4") activity (lanes): D, TK406; E, TK729; F, TK1043. APH(3')-III activity (lanes): G, MS353(pTU512); H, MS353(pTUO53); I, TK1265. Lane J contains the standard proteins (a) human albumin (molecular weight, 68,000), (b) ovalbumin (molecular weight, 45,000), (c) a-chymotrypsinogen A (molecular weight, 25,100).
A summary of the different AG-modifying enzymes from the strains tested in this study as well as their molecular weights and pl values are shown in Table 5 . The pl of APH(3')-III and that of the bifunctional enzyme with AAC(6') and APH(2") activity was 4.1, whereas that of AAD(4',4") was 4.7.
Immunological studies of AG-modifying enzymes. Immunological similarities between AG-modifying enzymes from S. aureus and S. epidermidis were studied by using antisera for APH(3')-III, AAC(6') and APH(2"), and AAD(4',4"). Antiserum obtained against APH(3')-III was placed in the center well as shown in Fig. 3A . The precipitin line was observed not only between the center well and that containing APH(3')-III purified from S. aureus MS353(pTU512), which had been used in the preparation of the antiserum, but also between the enzymes of APH(3')-III isolated from S. aureus MS353(pTUO53) and S. epidermidis TK1265. When enzymes isolated from other strains with different activities were tested, no precipitin line was produced. The results of the experiment in which the center well contained antiserum against AAC(6') and APH(2") activities are shown in Fig. 3B , and a similar experiment with antiserum obtained against AAD(4',4") is presented in Fig. 3C . In each case, the precipitin line was observed between the antiserum in the center well and the enzymes with identical activities which were purified from S. aureus and S. epidermidis. From these results, it may be suggested that AG-modifying enzymes in S. aureus and S. epidermidis are identical with respect to immunological specificity. DISCUSSION Studies on the mechanisms of resistance to AGs in S. aureus and S.epidermidis have been reported exclusively in the United States and Europe (3, 4, 13, 14, 17, 19, 20, 22, 26, FIG. 3. Immunodiffusion patterns of antisera to AG-modifying enzymes. (A) Antiserum to APH(3')-Ill from MS353(pTU512), (B) antiserum to bifunctional enzyme AAC(6') and APH(2") from MS353(pTUO68), and (C) antiserum to AAD(4',4") from TK729. Wells: 1, APH(3')-III from MS353(pTU512); 2, APH(3')-III from MS353(pTUO53); 3, AAC(6') and APH(2") from MS353(pTUO68); 4, AAD(4',4") from TK729; 5, APH(3')-III from TK1265; 6, AAC (6') and APH(2") from MS353(pTUO53); 7, AAC(6') and APH(2") from TK406; 8, AAD(4',4") from TK1043; 9, AAD(4',4") from TK406.
VOL. 25, 1984 on November 3, 2017 by guest http://aac.asm.org/ Downloaded from 28). In Japan between 1979 and 1980, we reported epidemiological studies on clinical isolates of S. aureus resistant to multiple AGs, including GM (9). When strains were tested for susceptibility to AGs, none was susceptible to GM and resistant to TOB. At that time, S-100 fractions prepared from several GM-resistant strains might have had AAC and APH activities. Further analysis of modified products of SISO and AMK by carbon magnetic resonance and phosphorus magnetic resonance spectra demonstrated that the 6'-NH2 had been acetylated and the 2"-OH had been phosphorylated simultaneously (24) . These results are in accordance with a previous report (12) which suggested that a single enzyme might be catalyzing the modification of 6'-NH2 and 2"-OH.
The degree of purification of the enzyme in that study was not sufficient to prove that a single enzyme was responsible for the two functions. Therefore, we reexamined the technical procedures employed in the purification of the enzyme and used affinity chromatography to attain a higher degree of purification. In these studies, transductant strains reported previously (10, 23) and some new wild-type strains of S. aureus and S. epidermidis that were resistant to AGs were used. The latter included strains that were susceptible to GM and resistant to TOB and AMK which have begun to appear in Japan. As described above, purification of the enzyme was almost sufficient when affinity chromatography was applied in combination with DEAE-Sephadex A-50 and Sephadex G-100 gel filtration. The enzymes thus obtained from each strain can be classified into three types. One is APH(3')-III whose major substrates are KM, AMK, and LVDM. Another is a bifunctional enzyme with AAC(6') and APH(2') activity modifying GM, SISO, TOB, AMK, and DKB. The third type is an AAD(4',4") which modifies KM, TOB, AMK, and DKB. Frequently, more than two types of enzyme were detected in extracts from the wild-type strains.
Our most remarkable finding was that the enzymes with identical functions purified from S. aureus and S. epidermidis also had the same molecular weight, pl, and immunological identity. Namely, APH(3')-III had a molecular weight of 31,000 and a pI of 4.1, the bifunctional enzyme with AAC(6') and APH(2') had a molecular weight of 54,000 and a pI of 4.1, and AAD(4',4") had a molecular weight of 36,000 and a pI of 4.7. Le Goffic (12) reported that the molecular weight of the bifunctional enzyme with AAC(6') and APH(2") activity from S. aureus Palm was estimated to be 28,000 with a pl of 5.7, whereas the AAD(4',4") from ApOl had a molecular weight of 22,000 and a pI of 5.1. On the other hand, Santanam et al. (21) found that the AAD(4',4") from S. epidermidis FK109 had a molecular weight of 46,770 and a pI of 5.0. Comparison of our results with those of these workers clearly indicates that with regard to the bifunctional enzyme having AAC(6') and APH(2") activity, we have obtained a higher molecular weight and also a different pI value.
We are now examining the enzymatic identity of other strains resistant to GM or AMK which have been isolated from other hospitals in different geographic areas. A comparative analysis demonstrates that these strains have enzymatic properties similar to those present in isolates from our hospital (unpublished data). Cohen et al. (2) demonstrated the presence of a common large plasmid mediating resistance to penicillin and GM in S. aureus and S. epidermidis and reported that this plasmid was transferred intra-and interspecifically between strains of S. aureus and S. epidermidis (16). Our two plasmids, i.e., pTUO53 mediating resistance to AGs, penicillin, and macrolides and pTUO68 mediating only AG resistance, are similarly large plasmids. The molecular weight of the former was 3.2 x 107, and that of the latter was 3.6 x 107 (23) .
The question remains as to whether these plasmids, isolated in different countries and mediating GM resistance, are similar and whether AG-modifying enzymes are immunologically identical.
LITERATURE CITED
